Prolactinomas, dopamine agonists and headache: two case reports

被引:79
|
作者
Levy, MJ
Matharu, MS
Goadsby, PJ
机构
[1] Inst Neurol, Headache Grp, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
关键词
continua; hemicrania; indomethacin; pituitary; SUNCT;
D O I
10.1046/j.1468-1331.2003.00549.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Headache is a common problem in patients with pituitary tumours. Small pituitary lesions can cause debilitating headache, suggesting that the size of the pituitary tumour may not be the only causal factor in pituitary-related headache. We present two cases of prolactinoma-associated headache. The first case has a clinical diagnosis of short-lasting unilateral headache attacks with conjunctival injection and tearing (SUNCT). The second case has a clinical diagnosis of hemicrania continua and idiopathic stabbing headache. In each case, the administration of dopamine agonists has led to an exacerbation of symptoms. We review the relevant literature to understand the pathophysiological implications of these cases.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [21] Metabolic effects of dopamine-agonists treatment among patients with prolactinomas
    Kabootari, Maryam
    Shirmohammadli, Habibeh
    Golgiri, Fatemeh
    Mosalamiaghili, Seyedarad
    Khajavi, Alireza
    Akbari, Hamideh
    ENDOCRINE, 2023, 79 (03) : 537 - 544
  • [22] Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment
    Colao, A
    DiSarno, A
    Sarnacchiaro, F
    Ferone, D
    DiRenzo, G
    Merola, B
    Annunziato, L
    Lombardi, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03): : 876 - 883
  • [23] CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas
    Leong, KS
    Foy, PM
    Swift, AC
    Atkin, SL
    Hadden, DR
    MacFarlane, IA
    CLINICAL ENDOCRINOLOGY, 2000, 52 (01) : 43 - 49
  • [24] Metabolic effects of dopamine-agonists treatment among patients with prolactinomas
    Maryam Kabootari
    Habibeh Shirmohammadli
    Fatemeh Golgiri
    Seyedarad Mosalamiaghili
    Alireza Khajavi
    Hamideh Akbari
    Endocrine, 2023, 79 : 537 - 544
  • [26] Cluster headache: When to worry? Two case reports
    Bellamio, Matteo
    Anglani, Mariagiulia
    Mainardi, Federico
    Zanchin, Giorgio
    Maggioni, Ferdinando
    CEPHALALGIA, 2017, 37 (05) : 491 - 495
  • [27] HEADACHE, HYPERPROLACTINEMIA, AND PROLACTINOMAS
    STREBEL, PM
    ZACUR, HA
    GOLD, EB
    OBSTETRICS AND GYNECOLOGY, 1986, 68 (02): : 195 - 199
  • [28] Determinants of Recurrent Hyperprolactinemia in Prolactinomas and Idiopatic Hyperprolactinemia after Dopamine Agonists Suspension
    Lau, Eva
    Oliveira, Joana Isabel
    Oliveira, Ana Isabel
    Freitas, Paula
    Vinha, Eduardo
    Carvalho, Davide
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [29] EFFECT OF THE PREOPERATIVE USE OF DOPAMINE AGONISTS IN THE POSTOPERATIVE COURSE OF PROLACTINOMAS: A SYSTEMATIC REVIEW
    Carija, Robert
    Tudor, Mario
    Vucina, Diana
    ENDOCRINE PRACTICE, 2014, 20 (01) : 70 - 74
  • [30] Surgical outcomes in hyporesponsive prolactinomas: Analysis of patients with resistance or intolerance to dopamine agonists
    Hamilton D.K.
    Vance M.L.
    Boulos P.T.
    Laws E.R.
    Pituitary, 2005, 8 (1) : 53 - 60